Tech Company Financing Transactions
Vasculox Funding Round
On 12/31/2014, Vasculox raised $1.3 million in financing from private investors.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$1,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Ave. 304
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Website
Email Address
Overview
Vasculox, Inc., is a biotechnology company focused on novel therapies for disorders driven by CD47 signaling pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Donovan
Chief Scientific Officer
Robert Karr
VP - Bus. Development
James Stutz
VP - Product Management
Bradley Keller
VP - R & D
Pamela Manning
Browse more venture capital transactions:
Prev: 12/31/2014: Quikly venture capital transaction
Next: 12/31/2014: Victorious venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs